Clinical Trials Browser

OTHER × Neoplasms × sipuleucel-T × Clear all

NCT01804465 2021-08-18

Sipuleucel-T With Immediate vs. Delayed Cytotoxic T-Lymphocyte-Associated Protein 4 (CTLA-4) Blockade for Prostate Cancer

Phase 2 Completed

50 enrolled 15 charts

Neoplasms, Prostatic Neoplasms